Pulmonary Fibrosis after Pegylated Liposomal Doxorubicin in Elderly Patient with Cutaneous Angiosarcoma
Introduction. Angiosarcoma is a rare cancer of the inner lining of blood vessels and can arise anywhere in the body, most commonly presenting as cutaneous disease in elderly patient, involving head and neck (H&N), especially the scalp. Pegylated liposomal doxorubicin (PLD) is one of the availabl...
Saved in:
| Main Authors: | Marco Mazzotta, Raffaele Giusti, Daniela Iacono, Salvatore Lauro, Paolo Marchetti |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Case Reports in Oncological Medicine |
| Online Access: | http://dx.doi.org/10.1155/2016/8034832 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Place of pegylated liposomal doxorubicin in the therapy of metastatic breast cancer
by: E. V. Artamonova
Published: (2016-09-01) -
The use of pegylated liposomal doxorubicin in metastatic soft tissue sarcoma
by: Trang Pham, et al.
Published: (2025-04-01) -
Diffuse Erythematous Follicular Eruption Induced by Pegylated Liposomal Doxorubicin
by: Zhong L, et al.
Published: (2025-04-01) -
Pegylated liposomal doxorubicin (Caelyx): contemporary aspects of its application in hematology
by: O. A. Rukavitsin, et al.
Published: (2022-11-01) -
Pegylated liposomal doxorubicin does not affect cardiac function in patients treated for gynecologic malignancies
by: Khrystyna Levytska, et al.
Published: (2025-04-01)